You may also like
Coronary Artery Bypass Confers Intermediate-Term Survival Benefit over Percutaneous Coronary Intervention with New-Generation Stents in Real-World Patients with Multivessel Coronary Artery Disease, Including Left Main Disease: A Retrospective Analysis of 6383 Patients
In this contemporary cohort of real-world patients with MVD, CABG was associated with increased intermediate-term survival compared to PCI with new-generation drug-eluting stents.
1 min read
A Promising Treatment for Athletes, in the Blood
Two of the Pittsburgh Steelers’ biggest stars, Hines Ward and Troy Polamalu, used their own blood in an innovative injury treatment before winning the Super Bowl.
7 min read
Controversies in the Clinical Practice of Patient Blood Management
This special article focuses on the current evidence and controversies in the clinical practice of PBM and on emerging data related to specific PBM-related interventions in patients undergoing cardiac surgery. Strong evidence for many PBM-related interventions is limited because of missing studies or the poor quality of published findings and study endpoints.
1 min read
